To further study the role of GSK3β in NK cells, we studied transcriptional changes in NK cells from AML patients which have been shown to overexpress GSK3β, to validate key genes identified as differentially expressed in GSK3B-KO NK cells. The gene discussed is GSK3B; the disease is acute myeloid leukemia.